DOJ probing Highmark’s proposed acquisition of West Penn Allegheny Health System
The Pittsburgh Tribune-Review reports that the DOJ is seeking documents related to the proposed $475 million acquisition of West Penn Allegheny Health System by Highmark. According to Paul Wood, University of Pittsburgh Medical Center (“UPMC”) spokesperson, the DOJ is looking into whether the deal will give Highmark more control over hospital service pricing and competition. Concerns have been raised because if Highmark continues to contract with UPMC after its acquisition, Highmark would be in a position to influence pricing at the two dominant hospital systems in the Pittsburgh area.
Featured News
Tech Policy and Regulation Weekly Roundup
Jan 23, 2026 by
CPI
Perkins Coie Adds Former DOJ Antitrust Leader as Partner in Washington
Jan 22, 2026 by
CPI
Ryanair Boss Dismisses Musk’s Buyout as Starlink Feud Escalates
Jan 22, 2026 by
CPI
Paramount Extends Warner Bros Bid as Netflix Rivalry Heats Up
Jan 22, 2026 by
CPI
South Korea Breaks New Ground With Landmark AI Law
Jan 22, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Recidivism
Jan 21, 2026 by
CPI
Recidivism, Multiple Offending, and Serial Offending in Antitrust
Jan 21, 2026 by
Gregory Werden
Antitrust Recidivism: Why Repeat Cases Appear, and Why True Reoffending Is Rare in the United States
Jan 21, 2026 by
Lisa M. Phelan, Megan S. Golden, Adrienne Irmer & Nina Worth
99 Antitrust Problems – Is Recidivism One?
Jan 21, 2026 by
Brian A. Ratner & Kartik S. Madiraju
Holding A Cat by the Tail: A View of Cartel Recidivism in U.S. Antitrust Enforcement
Jan 21, 2026 by
Mark Rosman & KaDee L. Ru